Evidence for pretreatment LICI deficits among depressed children and adolescents with nonresponse to fluoxetine

Brain Stimulation

Volumn 7, Issue 2, 2014, Pages 243-251

  Croarkin, Paul E ^a   Nakonezny, Paul A ^b   Husain, Mustafa M ^b   Port, John D ^a   Melton, Tabatha ^b   Kennard, Betsy D ^b   Emslie, Graham J ^b   Kozel, F Andrew ^c   Daskalakis, Zafiris J ^d  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Adolescents; Depression; Fluoxetine; GABA; LICI

Indexed keywords

4 AMINOBUTYRIC ACID; FLUOXETINE; GLUTAMIC ACID; ANTIDEPRESSANT AGENT;

ADOLESCENT; ADOLESCENT DISEASE; ADULT; ARTICLE; CHILD; CHILDHOOD DISEASE; CHILDREN DEPRESSION RATING SCALE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG TREATMENT FAILURE; EVOKED MUSCLE RESPONSE; FEMALE; HUMAN; INTRACORTICAL INHIBITION; LEFT HEMISPHERE; LONG INTERVAL CORTICAL INHIBITION; MAJOR DEPRESSION; MALE; MOTOR CORTEX; NEUROTRANSMISSION; PRIORITY JOURNAL; RATING SCALE; RIGHT HEMISPHERE; SCHOOL CHILD; SHORT INTERVAL INTRACORTICAL INHIBITION; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESPONSE; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; NERVE CELL INHIBITION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RETREATMENT; TREATMENT OUTCOME;

ADOLESCENT; ANTIDEPRESSIVE AGENTS; CHILD; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; EVOKED POTENTIALS, MOTOR; FEMALE; FLUOXETINE; HUMANS; MALE; MOTOR CORTEX; NEURAL INHIBITION; RETREATMENT; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84896399194     PISSN: 1935861X     EISSN: 18764754     Source Type: Journal    
DOI: 10.1016/j.brs.2013.11.006     Document Type: Article

References (67)

1. J.H. Krystal, G. Sanacora, H. Blumberg, A. Anand, D.S. Charney, and G. Marek et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments Mol Psychiatry 7 Suppl. 1 2002 S71 S80.
2. G. Sanacora, R. Gueorguieva, C.N. Epperson, Y.T. Wu, M. Appel, and D.L. Rothman et al. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression Arch Gen Psychiatry 61 7 2004 Jul 705 713.
3. R.B. Price, D.C. Shungu, X. Mao, P. Nestadt, C. Kelly, and K.A. Collins et al. Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder Biol Psychiatry 65 9 2009 May 1 792 800 [Epub 2008 Dec 5].
4. G. Rajkowska, G. O'Dwyer, Z. Teleki, C.A. Stockmeier, and J.J. Miguel-Hidalgo GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression Neuropsychopharmacology 32 2 2007 Feb 471 482 [Epub 2006 Oct 25].
5. M. Bajbouj, S.H. Lisanby, U.E. Lang, H. Danker-Hopfe, I. Heuser, and P. Neu Evidence for impaired cortical inhibition in patients with unipolar major depression Biol Psychiatry 59 5 2006 Mar 1 395 400 [Epub 2005 Sep 28].
6. A.J. Levinson, P.B. Fitzgerald, G. Favalli, D.M. Blumberger, M. Daigle, and Z.J. Daskalakis Evidence of cortical inhibitory deficits in major depressive disorder Biol Psychiatry 67 5 2010 Mar 1 458 464 [Epub 2009 Nov 17].
7. V. Gabbay, X. Mao, R.G. Klein, B.A. Ely, J.S. Babb, and A.M. Panzer et al. Anterior cingulate cortex γ-aminobutyric acid in depressed adolescents: relationship to anhedonia Arch Gen Psychiatry 69 2 2012 Feb 139 149 [Epub 2011 Oct 3].
8. S.A. Sands, S.A. Reisman, and S.J. Enna Effect of antidepressants on GABA(B) receptor function and subunit expression in rat hippocampus Biochem Pharmacol 68 8 2004 Oct 15 1489 1495.
9. D.S. McGehee GIRK channels as a target for SSRIs: focus on "reduced 5-HT1A- and GABAB receptor function in dorsal raphe neurons upon chronic fluoxetine treatment of socially stressed rats" J Neurophysiol 98 1 2007 Jul 1 2 [Epub 2007 May 16].
10. R.T. Robinson, B.C. Drafts, and J.L. Fisher Fluoxetine increases GABA(A) receptor activity through a novel modulatory site J Pharmacol Exp Ther 304 3 2003 Mar 978 984.
11. Z.Y. Ye, K.Q. Zhou, T.L. Xu, and J.N. Zhou Fluoxetine potentiates GABAergic IPSCs in rat hippocampal neurons Neurosci Lett 442 1 2008 Sep 5 24 29 [Epub 2008 Jul 1].
12. G. Sanacora, G.F. Mason, D.L. Rothman, and J.H. Krystal Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors Am J Psychiatry 159 4 2002 Apr 663 665.
13. A.T. Barker, R. Jalinous, and I.L. Freeston Non-invasive magnetic stimulation of human motor cortex Lancet 1 8437 1985 May 11 1106 1107.
14. S.M. McClintock, C. Freitas, L. Oberman, S.H. Lisanby, and A. Pascual-Leone Transcranial magnetic stimulation: a neuroscientific probe of cortical function in schizophrenia Biol Psychiatry 70 1 2011 Jul 1 19 27 [Epub 2011 May 14].
15. T. Kujirai, M.D. Caramia, J.C. Rothwell, B.L. Day, P.D. Thompson, and A. Ferbert et al. Corticocortical inhibition in human motor cortex J Physiol 471 1993 Nov 501 519.
16. P.B. Fitzgerald, T.L. Brown, and Z.J. Daskalakis The application of transcranial magnetic stimulation in psychiatry and neurosciences research Acta Psychiatr Scand 105 5 2002 May 324 340.
17. C.J. McNeil, P.G. Martin, S.C. Gandevia, and J.L. Taylor Long-interval intracortical inhibition in a human hand muscle Exp Brain Res 209 2 2011 Mar 287 297 [Epub 2011 Jan 26].
18. N.C. Rogasch, Z.J. Daskalakis, and P.B. Fitzgerald Mechanisms underlying long-interval cortical inhibition in the human motor cortex: a TMS-EEG study J Neurophysiol 109 1 2013 Jan 89 98 [Epub 2012 Oct 24].
19. B.W. Connors, R.C. Malenka, and L.R. Silva Two inhibitory postsynaptic potentials, and GABAA and GABAB receptor-mediated responses in neocortex of rat and cat J Physiol 406 1988 Dec 443 468.
20. U. Ziemann, S. Lonnecker, B.J. Steinhoff, and W. Paulus The effects of lorazepam on the motor cortical excitability in man Exp Brain Res 109 1 1996 Apr 127 135.
21. J. Florian, M. Muller-Dahlhaus, Y. Liu, and U. Ziemann Inhibitory circuits and the nature of their interactions in the human motor cortex a pharmacological TMS study J Physiol 586 2 2008 Jan 15 495 514 [Epub 2007 Nov 8].
22. M.N. McDonnell, Y. Orekhov, and U. Ziemann The role of GABA(B) receptors in intracortical inhibition in the human motor cortex Exp Brain Res 173 1 2006 Aug 86 93 [Epub 2006 Feb 18].
23. R.F. Cash, U. Ziemann, K. Murray, and G.W. Thickbroom Late cortical disinhibition in human motor cortex: a triple-pulse transcranial magnetic stimulation study J Neurophysiol 103 1 2010 Jan 511 518 [Epub 2009 Nov 18].
24. T.D. Sanger, R.R. Garg, and R. Chen Interactions between two different inhibitory systems in the human motor cortex J Physiol 530 Pt 2 2001 Jan 15 307 317.
25. C.H. Davies, S.N. Davies, and G.L. Collingridge Paired-pulse depression of monosynaptic GABA-mediated inhibitory postsynaptic responses in rat hippocampus J Physiol 424 1990 May 513 531.
26. R.A. Deisz GABA(B) receptor-mediated effects in human and rat neocortical neurones in vitro Neuropharmacology 38 11 1999 Nov 1755 1766.
27. U. Ziemann, R. Chen, L.G. Cohen, and M. Hallet Dextromethorphan decreases the excitability of the human motor cortex Neurology 51 5 1998 Nov 1320 1324.
28. U. Ziemann, J.C. Rothwell, and M.C. Ridding Interaction between intracortical inhibition and facilitation in human motor cortex J Physiol 496 Pt 3 1996 873 881.
29. R.E. Frye, A. Rotenberg, M. Ousley, and A. Pascual-Leone Transcranial magnetic stimulation in child neurology: current and future directions J Child Neurol 23 1 2008 Jan 79 96 [Epub 2007 Dec 3].
30. P.E. Croarkin, C.A. Wall, and J. Lee Applications of transcranial magnetic stimulation (TMS) in child and adolescent psychiatry Int Rev Psychiatry 23 5 2011 Oct 445 453.
31. J. Kaufman, B. Birmaher, D. Brent, U. Rao, C. Flynn, and P. Moreci et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data J Am Acad Child Adolesc Psychiatry 36 7 1997 Jul 980 988.
32. E.O. Poznanski, S.C. Cook, B.J. Carroll, and H. Corzo Use of the Children's Depression Rating Scale in an inpatient psychiatric population J Clin Psychiatry 44 6 1983 Jun 200 203.
33. A.J. Rush, M.H. Trivedi, H.M. Ibrahim, T.J. Carmody, B. Arnow, and D.N. Klein et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression Biol Psychiatry 54 5 2003 Sep 1 573 583 [Erratum in: Biol Psychiatry. 2003 Sep 1;54(5):585].
34. W. Guy ECDEU Assessment Manual for Psychopharmacology (028 Clinical Global Impressions [CGI]) 1976 National Institute of Mental Health Rockville, MD 218 222.
35. J.C. Keel, M.J. Smith, and E.M. Wassermann A safety screening questionnaire for transcranial magnetic stimulation Clin Neurophysiol 112 4 2001 Apr 720.
36. R.C. Oldfield The assessment and analysis of handedness: the Edinburgh inventory Neuropsychologia 9 1 1971 Mar 97 113.
37. A.S. Kaufman, and N.L. Kaufman Kaufman Brief Intelligence Test (KBIT-2) 2nd ed. 2004 American Guidance Service Circle Pines, MN.
38. M.G. Kenward, and J.H. Roger Small sample inference for fixed effects from restricted maximum likelihood Biometrics 53 3 1997 Sep 983 997.
39. Y. Benjamini, and Y. Hochberg Controlling the false discovery rate: a practical and powerful approach to multiple testing J R Stat Soc Series B Stat Methodol 57 1 1995 289 300.
40. P.E. Croarkin, P.A. Nakonezny, M.M. Husain, T. Melton, J.S. Buyukdura, and B.D. Kennard et al. Evidence for increased glutamatergic cortical facilitation in children and adolescents with major depressive disorder JAMA Psychiatry 70 3 2013 Mar 291 299.
41. P.E. Croarkin, A.J. Levinson, and Z.J. Daskalakis Evidence for GABAergic inhibitory deficits in major depressive disorder Neurosci Biobehav Rev 35 3 2011 Jan 818 825 [Epub 2010 Oct 12].
42. N.G. Bowery, D.R. Hill, A.L. Hudson, A. Doble, D.N. Middlemiss, and J. Shaw et al. (-)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor Nature 283 5742 1980 Jan 3 92 94.
43. W. Reimann Inhibition by GABA, baclofen and gabapentin of dopamine release from rabbit caudate nucleus: are there common or different sites of action? Eur J Pharmacol 94 3-4 1983 Oct 28 341 344.
44. T.P. Beauchaine, E. Neuhaus, S.L. Brenner, and L. Gatzke-Kopp Ten good reasons to consider biological processes in prevention and intervention research Dev Psychopathol 20 3 2008 Summer 745 774.
45. A. Stringaris In this issue/abstract thinking: clinical diagnoses and the future of biomarkers J Am Acad Child Adolesc Psychiatry 50 12 2011 Dec 1197 1198.
46. J.A. Bridge, S. Iyengar, C.B. Salary, R.P. Barbe, B. Birmaher, and H.A. Pincus et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials JAMA 297 15 2007 Apr 18 1683 1696.
47. D.L. McMakin, T.M. Olino, G. Porta, L.J. Dietz, G. Emslie, and G. Clarke et al. Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression J Am Acad Child Adolesc Psychiatry 51 4 2012 Apr 404 411 [Epub 2012 Mar 3].
48. A.V. Kalueff, and D.J. Nutt Role of GABA in anxiety and depression Depress Anxiety 24 7 2007 495 517.
49. Q.P. Wang, H. Ochiai, and Y. Nakai GABAergic innervation of serotonergic neurons in the dorsal raphe nucleus of the rat studied by electron microscopy double immunostaining Brain Res Bull 29 6 1992 Dec 943 948.
50. R. Tao, and S.B. Auerbach Regulation of serotonin release by GABA and excitatory amino acids J Psychopharmacol 14 2 2000 Jun 100 113.
51. P. Manganotti, M. Bortolomasi, G. Zanette, T. Pawelzik, M. Giacopuzzi, and A. Fiaschi Intravenous clomipramine decreases excitability of human motor cortex: a study with paired magnetic stimulation J Neurol Sci 184 1 2001 Feb 15 27 32.
52. E. Robol, A. Fiaschi, and P. Manganotti Effects of citalopram on the excitability of the human motor cortex: a paired magnetic stimulation study J Neurol Sci 221 1-2 2004 Jun 15 41 46.
53. A. Minelli, M. Bortolomasi, C. Scassellati, B. Salvoro, M. Avesani, and P. Manganotti Effects of intravenous antidepressant drugs on the excitability of human motor cortex: a study with paired magnetic stimulation on depressed patients Brain Stimul 3 1 2010 Jan 15 21 [Epub 2009 May 22].
54. K. Ohira, R. Takeuchi, H. Shoji, and T. Miyakawa Fluoxetine-induced cortical adult neurogenesis Neuropsychopharmacology 38 6 2013 May 909 920.
55. Y.G. Ni, and R. Miledi Blockage of 5HT2C serotonin receptors by fluoxetine (Prozac) Proc Natl Acad Sci U S A 94 5 1997 Mar 4 2036 2040.
56. J. Serrats, G. Mengod, and R. Cortes Expression of serotonin 5-HT2C receptors in GABAergic cells of the anterior raphe nuclei J Chem Neuroanat 29 2 2005 Mar 83 91.
57. R.W. Invernizzi, M. Pierucci, E. Calcagno, G. Di Giovanni, V. Di Matteo, and A. Benigno et al. Selective activation of the 5-HT(2C) receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study Neuroscience 144 4 2007 Feb 23 1523 1535 [Epub 2006 Dec 8].
58. A.A. Khundakar, and T.S. Zetterstrom Effects of GABAB ligands alone and in combination with paroxetine on hippocampal BDNF gene expression Eur J Pharmacol 671 1-3 2011 Dec 5 33 38 [Epub 2011 Sep 14].
59. R. Andrade, R.C. Malenka, and R.A. Nicoll A G protein couples serotonin and GABAB receptors to the same channels in hippocampus Science 234 4781 1986 Dec 5 1261 1265.
60. D.A. Slattery, S. Desrayaud, and J.F. Cryan GABAB receptor antagonist-mediated antidepressant-like behavior is serotonin-dependent J Pharmacol Exp Ther 312 1 2005 Jan 290 296 [Epub 2004 Aug 27].
61. S.J. Enna, and N.G. Bowery GABA(B) receptor alterations as indicators of physiological and pharmacological function Biochem Pharmacol 68 8 2004 Oct 1541 1548.
62. Z.J. Daskalakis, F. Farzan, M.S. Barr, J.J. Maller, R. Chen, and P.B. Fitzgerald Long-interval cortical inhibition from the dorsolateral prefrontal cortex: a TMS-EEG study Neuropsychopharmacology 33 12 2008 Nov 2860 2869 [Epub 2008 Mar 5].
63. F. Farzan, M.S. Barr, A.J. Levinson, R. Chen, W. Wong, and P.B. Fitzgerald et al. Reliability of long-interval cortical inhibition in healthy human subjects: a TMS-EEG study J Neurophysiol 104 3 2010 Sep 1339 1346 [Epub 2010 Jun 23].
64. F. Farzan, M.S. Barr, W. Wong, R. Chen, P.B. Fitzgerald, and Z.J. Daskalakis Suppression of gamma-oscillations in the dorsolateral prefrontal cortex following long interval cortical inhibition: a TMS-EEG study Neuropsychopharmacology 34 6 2009 May 1543 1551 [Epub 2008 Nov 26].
65. K.F. Heise, M. Zimerman, J. Hoppe, C. Gerloff, K. Wegscheider, and F.C. Hummel The aging motor system as a model for plastic changes of GABA-mediated intracortical inhibition and their behavioral relevance J Neurosci 33 21 2013 May 22 9039 9049.
66. C.J. Stagg, S. Bestmann, A.O. Constantinescu, L.M. Moreno, C. Allman, and R. Mekle et al. Relationship between physiological measures of excitability and levels of glutamate and GABA in the human motor cortex J Physiol 589 Pt 23 2011 Dec 1 5845 5855 [Epub 2011 Oct 17].
67. U. Ziemann, M. Wahl, E. Hattingen, and H. Tumani Development of biomarkers for multiple sclerosis as a neurodegenerative disorder Prog Neurobiol 95 4 2011 Dec 670 685 [Epub 2011 Apr 16]